Please provide your email address to receive an email when new articles are posted on . Baxter International said in a recent 8K report filing it would consider a sale of its kidney division vs.
Baxter calculates forward-looking non-GAAP financial measures based on forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, forward-looking operational ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2023 financial results on Thursday, November 2 ...
HIRC award reinforces Baxter’s industry leadership in preparing for and responding to supply chain disruptions Recognition builds on the HIRC Transparency Badge earned by Baxter in 2023 and 2024, ...
Establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources Sale follows robust process focused on maximizing stockholder value Provides ...
Provides updates on Baxter’s 2030 Corporate Responsibility Commitment and Goals and reinforces the company’s commitment to transparent reporting “Baxter employees across the globe are connected by our ...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday, May 6, 2025 at 9 a.m., Central ...
Dynamo Series, Baxter International Inc. “At Baxter, we are committed to driving focused innovation that empowers clinicians to deliver exceptional patient care in high-pressure environments,” said ...
DEERFIELD, IL – Baxter International Inc. (NYSE:BAX), a global leader in medical products with a market capitalization of $16.65 billion and annual revenue of $15.06 billion, announced today the ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026. Andrew Hider, ...
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (BAX), a global medtech leader, today reported results for the first quarter of 2025. “Our solid performance in the first quarter of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results